{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-089693","form_type":"8-K","ticker":"ACTU","cik":"0001652935","company_name":"ACTUATE THERAPEUTICS, INC.","filed_at":"2024-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.973648+00:00","generated_at":"2026-05-31T09:21:30.616500+00:00","sec_items":["5.02","5.03","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Actuate Therapeutics completes IPO of 2.8M shares at $8.00, net proceeds $19.2M","bullets":["IPO closed Aug 14, 2024: 2,800,000 shares at $8.00/share, net proceeds $19.2M.","Underwriters granted 30-day option to purchase up to 420,000 additional shares.","New independent directors appointed: Jason Keyes, Roger Sawhney, Amy Ronneberg; Les Kreis resigned.","Charter amended: authorized common stock increased to 200M shares; classified board created.","Exclusive forum provisions for federal securities law claims adopted in charter."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-089693","json":"https://secwatch.observer/filing/0001104659-24-089693.json","markdown":"https://secwatch.observer/filing/0001104659-24-089693.md","text":"https://secwatch.observer/filing/0001104659-24-089693.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089693/0001104659-24-089693-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089693/tm2419022d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T09:21:30.616500+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c3857bed8","claim":"Amy Ronneberg was appointed as Director at ACTUATE THERAPEUTICS, INC..","evidence_excerpt":"each of Jason Keyes, Roger Sawhney, and Amy Ronneberg were appointed to the Company’s Board of Directors (the “Board”) on May 20, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089693/0001104659-24-089693-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7e3f7808a4","claim":"Jason Keyes was appointed as Director at ACTUATE THERAPEUTICS, INC..","evidence_excerpt":"each of Jason Keyes, Roger Sawhney, and Amy Ronneberg were appointed to the Company’s Board of Directors (the “Board”) on May 20, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089693/0001104659-24-089693-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"99c5410459","claim":"Roger Sawhney was appointed as Director at ACTUATE THERAPEUTICS, INC..","evidence_excerpt":"each of Jason Keyes, Roger Sawhney, and Amy Ronneberg were appointed to the Company’s Board of Directors (the “Board”) on May 20, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089693/0001104659-24-089693-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"b65c4a3133","claim":"Les Kreis, Jr. resigned as Director at ACTUATE THERAPEUTICS, INC..","evidence_excerpt":"Les Kreis, Jr. resigned from the Board effective immediately prior to the closing of the Company’s initial public offering.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1652935/000110465924089693/0001104659-24-089693-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}